Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Discover which cards provide rewards without annual fees. Enjoy benefits while keeping your expenses low.
26,068 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Investors are torn on Amazon stock as AI hype collides with earnings reality. This guide offers a clear framework to ...
Argus boosts Exxon Mobil's target to $169, signaling confidence in higher 2026 output from Permian and Guyana and a r...
A new White House mascot, meet ‘coalie,’ anime-style anthropomorphic coal, is shaping how investors view energy polic...
Bond traders pushed yields to fresh highs, tightening liquidity and pulling Bitcoin off its latest rally. The move un...
A timely analysis of pff’s billion preferred stock exposure reveals how call provisions and a bank-heavy portfolio co...
Snowflake delivered a strong fiscal quarter and unveiled a major AWS commitment, sending the stock higher. This guide...
Three mid-cap SaaS stocks are under renewed activist scrutiny as AI-fit strategies collide with balance-sheet pressur...
A leading hedge fund investor says the current AI rally is fundamentally different from the late-1990s bubble, citing...
June 2026 shifts spotlight to Tesla and BYD as margin rebound meets policy tailwinds. Here’s the latest data and what...
Bitcoin dipped under $63,000 as oil markets steadied and shipping through the Strait of Hormuz resumed. The move come...
Micron Technology faces its Q3 print after a sharp 13% drop on Tuesday, as investors weigh memory demand against AI i...